tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Blueprint Medicines price target raised to $129 from $88 at UBS
PremiumThe FlyBlueprint Medicines price target raised to $129 from $88 at UBS
4M ago
Blueprint Medicines price target raised to $129 from $102 at Morgan Stanley
Premium
The Fly
Blueprint Medicines price target raised to $129 from $102 at Morgan Stanley
4M ago
Hold Rating on Blueprint Medicines Amid Sanofi Acquisition and Market Uncertainties
Premium
Ratings
Hold Rating on Blueprint Medicines Amid Sanofi Acquisition and Market Uncertainties
4M ago
Blueprint Medicines downgraded to Equal Weight from Overweight at Stephens
PremiumThe FlyBlueprint Medicines downgraded to Equal Weight from Overweight at Stephens
4M ago
Blueprint downgraded to Market Perform from Outperform at Citizens JMP
Premium
The Fly
Blueprint downgraded to Market Perform from Outperform at Citizens JMP
4M ago
Blueprint Medicines downgraded to Hold from Buy at TD Cowen
Premium
The Fly
Blueprint Medicines downgraded to Hold from Buy at TD Cowen
4M ago
Blueprint Medicines downgraded to Hold from Buy at Needham
PremiumThe FlyBlueprint Medicines downgraded to Hold from Buy at Needham
4M ago
Morning Movers: Trump to bump steel tariffs, pharma companies announce deals
Premium
The Fly
Morning Movers: Trump to bump steel tariffs, pharma companies announce deals
4M ago
Blueprint Medicines downgraded to Neutral from Outperform at Wedbush
Premium
The Fly
Blueprint Medicines downgraded to Neutral from Outperform at Wedbush
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100